SedMed Raises $4 Million in Latest Funding Round
SedMed, a company focused on enhancing mobility and support for individuals transitioning from sitting to standing, announced that it has raised $4 million in a recent funding round. The round was led by 108 BioCapital, although other investors were not disclosed.
SedMed, headquartered in Milford, Connecticut, specializes in creating non-electric toilet seat assist devices that aim to promote independence for users and provide support for caregivers. This innovative product is designed to minimize the risk of falls and reduce the force of hard landings during sit-to-stand movements.
Leadership and Vision
The company was founded by Jeremy Bronen, who also serves as its CEO. Bronen has been instrumental in driving the company's mission to enhance safety and independence for users. While specific comments from Bronen were not available, his leadership has been pivotal in securing this latest investment.
Use of Funds
Although specific plans for the newly acquired funds were not detailed, it is likely that the investment will be used to further develop SedMed's product offerings and possibly expand its market reach. Enhancing the current product line and exploring new markets could be on the horizon for the company.
About the Investors
108 BioCapital, the lead investor for this round, is known for backing companies in the healthcare and biotech sectors, suggesting a strategic alignment with SedMed's focus on improving health and safety through innovative solutions.
This funding marks a significant milestone for SedMed as it continues to develop its product suite aimed at fostering independence and safety for its users.